Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-03-12
1999-09-28
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
424451, 530317, A61K 3800, A61K 948
Patent
active
059588764
ABSTRACT:
The present invention relates to a cyclosporin-containing soft capsule preparation which contains a composition containing cyclosporin as an active ingredient; a non-hydrophilic component propylene carbonate or a mixture of propylene carbonate and a hydrophilic component polyethylene glycol, one or a mixture of two or more selected from the group consisting of an esterified compound of fatty acid and primary alcohol, medium chain fatty acid triglyceride and fatty acid monoglyceride as an oil component; and a surfactant having an HLB (Hydrophilic Lipophilic Balance) value of 8 to 17.
REFERENCES:
patent: 4388307 (1983-06-01), Cavanak
patent: 5342625 (1994-08-01), Hauer et al.
patent: 5589455 (1996-12-01), Woo
patent: 5626872 (1997-05-01), Vasquez
Wade et al., Handbook of Pharmaceutical Excipients (1994), pp. 355-361, 648.
Ainley Wade and Paul J. Weller, (eds.), Handbook of Pharmaceutical Excipients, 2nd ed., "Propylene Carbonate," pp. 405-406.
Novartis AG
Tsang Cecilia J.
Wissing William K.
LandOfFree
Cyclosporin-containing pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclosporin-containing pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclosporin-containing pharmaceutical compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-703190